ID   IFM3_RAT                Reviewed;         137 AA.
AC   P26376; B5DER6;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1992, sequence version 1.
DT   24-JUL-2024, entry version 146.
DE   RecName: Full=Interferon-induced transmembrane protein 3 {ECO:0000305};
DE   AltName: Full=Dispanin subfamily A member 2b;
DE            Short=DSPA2b;
GN   Name=ifitm3 {ECO:0000312|EMBL:CAA43655.1};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INDUCTION.
RX   PubMed=1639276; DOI=10.1016/0378-1119(92)90739-c;
RA   Hayzer D.J., Brinson E., Runge M.S.;
RT   "A rat beta-interferon-induced mRNA: sequence characterization.";
RL   Gene 117:277-278(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pituitary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RA   Mural R.J., Li P.W., Adams M.D., Amanatides P.G., Baden-Tillson H.,
RA   Barnstead M., Chin S.H., Dew I., Evans C.A., Ferriera S., Flanigan M.,
RA   Fosler C., Glodek A., Gu Z., Holt R.A., Jennings D., Kraft C.L., Lu F.,
RA   Nguyen T., Nusskern D.R., Pfannkoch C.M., Sitter C., Sutton G.G.,
RA   Venter J.C., Wang Z., Woodage T., Zheng X.H., Zhong F.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   GENE FAMILY.
RX   PubMed=22363774; DOI=10.1371/journal.pone.0031961;
RA   Sallman Almen M., Bringeland N., Fredriksson R., Schioth H.B.;
RT   "The dispanins: a novel gene family of ancient origin that contains 14
RT   human members.";
RL   PLoS ONE 7:E31961-E31961(2012).
CC   -!- FUNCTION: IFN-induced antiviral protein which disrupts intracellular
CC       cholesterol homeostasis. Inhibits the entry of viruses to the host cell
CC       cytoplasm by preventing viral fusion with cholesterol depleted
CC       endosomes. May inactivate new enveloped viruses which buds out of the
CC       infected cell, by letting them go out with a cholesterol depleted
CC       membrane. Active against multiple viruses. Plays a critical role in the
CC       structural stability and function of vacuolar ATPase (v-ATPase).
CC       Establishes physical contact with the v-ATPase of endosomes which is
CC       critical for proper clathrin localization and is also required for the
CC       function of the v-ATPase to lower the pH in phagocytic endosomes thus
CC       establishing an antiviral state. {ECO:0000250|UniProtKB:Q01628,
CC       ECO:0000250|UniProtKB:Q9CQW9}.
CC   -!- SUBUNIT: Interacts with ATP6V0B (By similarity). Interacts with CD81
CC       (By similarity). Interacts with SPP1; the interaction reduces OPN
CC       expression (By similarity). Interacts with BRI3 (By similarity).
CC       {ECO:0000250|UniProtKB:Q01628, ECO:0000250|UniProtKB:Q9CQW9}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q01628};
CC       Single-pass type II membrane protein {ECO:0000250|UniProtKB:Q01628}.
CC       Late endosome membrane {ECO:0000250|UniProtKB:Q01628}; Single-pass type
CC       II membrane protein {ECO:0000250|UniProtKB:Q01628}. Early endosome
CC       membrane {ECO:0000250|UniProtKB:Q01628}; Single-pass type II membrane
CC       protein {ECO:0000250|UniProtKB:Q01628}. Lysosome membrane
CC       {ECO:0000250|UniProtKB:Q01628}; Single-pass type II membrane protein
CC       {ECO:0000250|UniProtKB:Q01628}. Cytoplasm, perinuclear region
CC       {ECO:0000250|UniProtKB:Q01628}. Note=Co-localizes with BRI3 isoform 1
CC       at the perinuclear region. {ECO:0000250|UniProtKB:Q01628}.
CC   -!- INDUCTION: By interferon beta. {ECO:0000269|PubMed:1639276}.
CC   -!- PTM: Polyubiquitinated with both 'Lys-48' and 'Lys-63' linkages.
CC       Ubiquitination negatively regulates antiviral activity. Lys-24 is the
CC       most prevalent ubiquitination site. {ECO:0000250|UniProtKB:Q01628}.
CC   -!- PTM: Phosphorylation at Tyr-20 is required for endosomal and lysosomal
CC       location. {ECO:0000250|UniProtKB:Q01628}.
CC   -!- SIMILARITY: Belongs to the CD225/Dispanin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X61381; CAA43655.1; -; mRNA.
DR   EMBL; BC168774; AAI68774.1; -; mRNA.
DR   EMBL; CH473953; EDM11956.1; -; Genomic_DNA.
DR   PIR; JC1241; JC1241.
DR   RefSeq; NP_001129596.1; NM_001136124.1.
DR   AlphaFoldDB; P26376; -.
DR   SMR; P26376; -.
DR   BioGRID; 262866; 1.
DR   IntAct; P26376; 1.
DR   STRING; 10116.ENSRNOP00000020265; -.
DR   iPTMnet; P26376; -.
DR   PhosphoSitePlus; P26376; -.
DR   SwissPalm; P26376; -.
DR   PaxDb; 10116-ENSRNOP00000020265; -.
DR   Ensembl; ENSRNOT00000020265.8; ENSRNOP00000020265.4; ENSRNOG00000015078.8.
DR   Ensembl; ENSRNOT00055050145; ENSRNOP00055041275; ENSRNOG00055028964.
DR   Ensembl; ENSRNOT00060048132; ENSRNOP00060040055; ENSRNOG00060027743.
DR   Ensembl; ENSRNOT00065031615; ENSRNOP00065025207; ENSRNOG00065018823.
DR   GeneID; 361673; -.
DR   KEGG; rno:361673; -.
DR   AGR; RGD:1595844; -.
DR   CTD; 10410; -.
DR   eggNOG; ENOG502S9XK; Eukaryota.
DR   GeneTree; ENSGT00950000182857; -.
DR   HOGENOM; CLU_124511_3_0_1; -.
DR   InParanoid; P26376; -.
DR   OMA; WAPWITT; -.
DR   OrthoDB; 5322528at2759; -.
DR   PhylomeDB; P26376; -.
DR   TreeFam; TF334894; -.
DR   Reactome; R-RNO-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   PRO; PR:P26376; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Proteomes; UP000234681; Chromosome 1.
DR   Bgee; ENSRNOG00000015078; Expressed in ovary and 20 other cell types or tissues.
DR   GO; GO:0031901; C:early endosome membrane; ISS:UniProtKB.
DR   GO; GO:0031902; C:late endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005765; C:lysosomal membrane; ISS:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0051607; P:defense response to virus; IBA:GO_Central.
DR   GO; GO:0046597; P:negative regulation of viral entry into host cell; ISS:UniProtKB.
DR   GO; GO:0045071; P:negative regulation of viral genome replication; IBA:GO_Central.
DR   GO; GO:0035455; P:response to interferon-alpha; IBA:GO_Central.
DR   GO; GO:0035456; P:response to interferon-beta; IBA:GO_Central.
DR   GO; GO:0034341; P:response to type II interferon; IBA:GO_Central.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; IBA:GO_Central.
DR   InterPro; IPR007593; CD225/Dispanin_fam.
DR   InterPro; IPR051517; IFITM_antiviral_protein.
DR   PANTHER; PTHR13999; INTERFERON INDUCIBLE TRANSMEMBRANE PROTEIN; 1.
DR   PANTHER; PTHR13999:SF4; INTERFERON-INDUCED TRANSMEMBRANE PROTEIN 3; 1.
DR   Pfam; PF04505; CD225; 1.
PE   2: Evidence at transcript level;
KW   Antiviral defense; Cell membrane; Cytoplasm; Endosome; Isopeptide bond;
KW   Lipoprotein; Lysosome; Membrane; Palmitate; Phosphoprotein;
KW   Reference proteome; Signal-anchor; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   CHAIN           1..137
FT                   /note="Interferon-induced transmembrane protein 3"
FT                   /id="PRO_0000153730"
FT   TOPO_DOM        1..57
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   INTRAMEM        58..78
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        79..109
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        110..130
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        131..137
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   REGION          60..93
FT                   /note="Interaction with SPP1"
FT                   /evidence="ECO:0000250|UniProtKB:Q01628"
FT   REGION          108..133
FT                   /note="Interaction with VAPA"
FT                   /evidence="ECO:0000250|UniProtKB:Q01628"
FT   MOD_RES         20
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01628"
FT   MOD_RES         27
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9CQW9"
FT   LIPID           71
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01628"
FT   LIPID           72
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01628"
FT   LIPID           105
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01628"
FT   CROSSLNK        24
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q01628"
FT   CROSSLNK        83
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q01628"
FT   CROSSLNK        88
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q01628"
FT   CROSSLNK        104
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q01628"
SQ   SEQUENCE   137 AA;  14971 MW;  9D3F92264E0C0FC2 CRC64;
     MNHTSQAFVN AATGGQPPNY ERIKEEYEVS ELGAPHGSAS VRTTVINMPR EVSVPDHVVW
     SLFNTLFMNF CCLGFIAYAY SVKSRDRKMV GDMTGAQAYA STAKCLNISS LVLSILMVII
     TIVTVVIIAL NAPRLQT
//
